Preliminary evaluation of hepatitis A virus cell receptor 1/kidney injury molecule 1 in healthy horses treated with phenylbutazone
Journal of Veterinary Emergency and Critical Care · 2023
DOI: 10.1111/vec.13314 ↗At a glance
Journal article in Journal of Veterinary Emergency and Critical Care, 2023. Written by Lais R R Costa and 3 co-authors. Institution: Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, California, USA. Major MEDLINE topics: Anti-Inflammatory Agents, Non-Steroidal, Hepatitis A virus. Cited 2 times so far (Crossref); 17 references.
Abstract (original language)
Objectives
To investigate if hepatitis A virus cell receptor 1/kidney injury molecule 1 (HAVCR1/KIM1) in urine is detectable concurrently with increases in serum creatinine concentrations in horses receiving a recommended dose of phenylbutazone (PBZ) for 7 days.
Design
Preliminary study.
Methods
Ten clinically healthy horses with normal physical examination and laboratory work were randomly assigned to PBZ or placebo groups (5 each). The PBZ group received PBZ at 4.4 mg/kg mixed with corn syrup orally every 12 hours. The placebo group received corn syrup orally every 12 hours. Both groups were treated for 7 days. Kidney ultrasonography was performed, and venous blood and urine samples were collected prior to commencement and at the end of treatment. Samples from 1 additional healthy horse, 3 horses with acute kidney failure, and 1 horse with chronic kidney failure were also evaluated.
Results
None of the 10 horses had detectable HAVCR1/KIM1 in urine at baseline. Serum creatinine concentrations in placebo group did not increase, and HAVCR1/KIM1 was undetectable in urine. At the end of treatment, 3 of 5 horses receiving PBZ developed increases in serum creatinine of >26.5 μmol/L (>0.3 mg/dL), and HAVCR1/KIM1 was detectable in urine, despite normal findings on kidney ultrasonography in all horses.
Conclusions
HAVCR1/KIM1 is detectable in urine and is associated with increases in serum creatinine concentrations of >26.5 μmol/L in horses following treatment with PBZ for 7 consecutive days. Thus, HAVCR1/KIM1 might aid in the early detection of acute kidney injury in horses.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
- Department of Pathobiology and Population Medicine, School of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
ORCID profiles: Monica Aleman
Cite
APA
Costa, L. R. R., Swiderski, C., Palm, C., & Aleman, M. (2023). Preliminary evaluation of hepatitis A virus cell receptor 1/kidney injury molecule 1 in healthy horses treated with phenylbutazone. Journal of Veterinary Emergency and Critical Care. https://doi.org/10.1111/vec.13314
Vancouver
Costa LRR, Swiderski C, Palm C, Aleman M. Preliminary evaluation of hepatitis A virus cell receptor 1/kidney injury molecule 1 in healthy horses treated with phenylbutazone. Journal of Veterinary Emergency and Critical Care. 2023. doi:10.1111/vec.13314
BibTeX
@article{Costa2023,
author = {Costa, Lais R R and Swiderski, Cyprianna and Palm, Carrie and Aleman, Monica},
title = {Preliminary evaluation of hepatitis A virus cell receptor 1/kidney injury molecule 1 in healthy horses treated with phenylbutazone},
journal = {Journal of Veterinary Emergency and Critical Care},
year = {2023},
doi = {10.1111/vec.13314}
}
EUVIMED